News
New FDA Draft Guideline for Oligonucleotide Therapeutics
In June 2022 the FDA published a draft version of a new guideline about “Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics”. The guideline provides recommendations to assist the industry in the development of (...) Read more
Kymos at CPHI 2022 in Frankfurt, Booth #41L60
We are this year exhibiting at CPHI together with our partners Ascil, Mitelos and Ricerpharma at booth #41L60. Maybe you do not know yet that we newly own a Dissolution IV and an Orbitrap system? Or would you (...) Read more
Solar Panels at Kymos
Climate change, gas and electricity crisis, high inflation. These are challenges all of us are facing every day. Kymos is now taking action: We have invested in sustainability and in our future with new SolarPannels (...) Read more
Kymos Workshop at Farmaforum: Recent trends in the impurity profile of pharmaceuticals
Come to our workshop and learn more about impurity testing. Learn from firsthand experience. Our experts present real case studies from their daily work. Agenda: The challenge of Impurities in Pharmaceuticals. Jaume Pascual - Quality (...) Read more
Subscribe here to be updated in the latest regulatory, technological and innovation news.
